Patent · US Active

Method of producing an immunoligand/payload conjugate

US11364301B2 · kind B2 · utility

3Cited by

7References

20Claims

0Family size

Assignee

NBE-Therapeutics AG · CH

Inventors

Ulf Grawunder · Basel, CH
Roger Beerli · Adlikon, CH

Key dates

Filing date	Jun 29, 2020
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Jul 7, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2521/537
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of producing an immunoligand/payload conjugate, which method encompasses conjugating a payload to an immunoligand by means of a sequence-specific transpeptidase, or a catalytic domain thereof (FIG. 6B).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.